Anebulo Pharmaceuticals Inc (ANEB)

Official site

BIOTECHNOLOGY

$0.31

-0.00 (-1.59%)

Last updated: Oct 14, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

55%(11/20)

Avg Surprise

-335.24%

Streak

4 Q

Upcoming Estimates

Period ending Jun 30, 2026

EPS Consensus$-0.09

Range$-0.09 - $-0.09

1 analysts

Revenue Consensus

Range$0 - $0

0 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26EST	-	$-0.09	$-0.09 - $-0.09	-	-	1	-	-
Dec 31, 2025Dec 25 Reported Feb 12, 2026Reported Feb 12	$-0.05	N/A	-	+61.54%	Beat	1	No revisions (30d)	+44.3%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-0.05	N/A	-	+58.33%	Beat	1	No revisions (30d)	+41.1%
Jun 30, 2025Jun 25 Reported Sep 29, 2025Reported Sep 29	$-0.05	$-0.05	$-0.05 - $-0.05	+0.00%	Beat	1	1 0 30d	+0.0%
Mar 31, 2025Mar 25 Reported May 13, 2025Reported May 13	$-0.04	$-0.05	$-0.05 - $-0.05	+20.00%	Beat	1	1 0 30d	+33.3%
Dec 31, 2024Dec 24 Reported Feb 11, 2025Reported Feb 11	$-0.09	$-0.08	$-0.08 - $-0.08	-12.25%	Miss	1	No revisions (30d)	+18.4%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-0.08	$-0.05	$-0.05 - $-0.05	-69.80%	Miss	1	No revisions (30d)	+15.1%
Jun 30, 2024Jun 24 Reported Sep 25, 2024Reported Sep 25	$-0.05	N/A	-	+61.54%	Beat	0	No revisions (30d)	+50.0%
Mar 31, 2024Mar 24 Reported May 15, 2024Reported May 15	$-0.06	$-0.12	$-0.13 - $-0.11	+50.00%	Beat	2	No revisions (30d)	+45.5%
Dec 31, 2023Dec 23 Reported Feb 13, 2024Reported Feb 13	$-0.11	$-0.10	$-0.10 - $-0.10	-10.00%	Miss	1	No revisions (30d)	+26.7%
Sep 30, 2023Sep 23 Reported Nov 14, 2023Reported Nov 14	$-0.10	$-0.12	$-0.13 - $-0.11	+16.67%	Beat	3	No revisions (30d)	+9.1%
Jun 30, 2023Jun 23 Reported Sep 20, 2023Reported Sep 20	$-0.10	$-0.11	$-0.12 - $-0.11	+9.09%	Beat	2	No revisions (30d)	+0.0%
Mar 31, 2023Mar 23 Reported May 11, 2023Reported May 11	$-0.11	$-0.16	$-0.16 - $-0.15	+31.25%	Beat	2	No revisions (30d)	-37.5%
Dec 31, 2022Dec 22 Reported Feb 10, 2023Reported Feb 10	$-0.15	$-0.11	$-0.12 - $-0.10	-36.36%	Miss	2	No revisions (30d)	-200.0%
Sep 30, 2022Sep 22 Reported Nov 10, 2022Reported Nov 10	$-0.11	$-0.10	$-0.11 - $-0.10	-10.00%	Miss	2	No revisions (30d)	-57.1%
Jun 30, 2022Jun 22 Reported Sep 9, 2022Reported Sep 9	$-0.10	$-0.07	-	-42.86%	Miss	2	No revisions (30d)	+93.7%
Mar 31, 2022Mar 22 Reported May 11, 2022Reported May 11	$-0.08	$-0.05	$-0.05 - $-0.05	-60.00%	Miss	1	No revisions (30d)	+88.4%
Dec 31, 2021Dec 21 Reported Feb 11, 2022Reported Feb 11	$-0.05	$-0.06	-	+16.67%	Beat	1	No revisions (30d)	+0.0%
Sep 30, 2021Sep 21 Reported Nov 12, 2021Reported Nov 12	$-0.07	$-0.11	$-0.11 - $-0.11	+36.36%	Beat	1	No revisions (30d)	+48.9%
Jun 30, 2021Jun 21 Reported Sep 22, 2021Reported Sep 22	$-1.59	$-0.03	$-0.03 - $-0.03	-5200.00%	Miss	1	No revisions (30d)	-1061.4%
Mar 31, 2021Mar 21 Reported Jun 21, 2021Reported Jun 21	$-0.69	$-0.04	-	-1625.00%	Miss	-	-	-
Dec 31, 2020Dec 20 Reported Mar 3, 2021Reported Mar 3	$-0.05	$0.00	-	N/A	Miss	-	-	-
Sep 30, 2020Sep 20 Reported Dec 31, 2020Reported Dec 31	$-0.14	$0.00	-	N/A	Miss	-	-	-
Jun 30, 2020Jun 20 Reported Sep 30, 2020Reported Sep 30	$-0.14	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	-2.18x	FCF Yield	-45.86%
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	-26.86x
Current Ratio	6.24x	Quick Ratio	6.24x
Trading Statistics
Beta	N/A	Avg Volume	221
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$0.32

SMA 20$0.32

SMA 50$0.33

SMA 200$0.52

EMA 10$0.32

EMA 20$0.32

EMA 50$0.33

EMA 200$0.63

MACD

Line: -0.00Signal: -0.00Hist: -0.00

ADX

ADX: 52.2+DI: 19.8-DI: 71.7

Aroon & PSAR

Aroon Up20.0

Aroon Down16.0

PSAR$0.05

Bollinger Bands

Upper Band$0.33

Lower Band$0.30

%B Position999%(Upper)

Band Width0.28

RSI (14-Day)

Neutral

44.4

Momentum Oscillators

Stoch %K53.3

Stoch %D55.6

Williams %R-60.0

ROC (10d)-3.1%

Momentum-0.01

CCI (20d)-80.9

MFI (14d)11.8

Volatility Measures

ATR (14d)$0.01(4.8%)

StdDev (20d)0.01

Hist Vol61.1%(High)

Volume Flow

VWAP$0.31

OBV14.5M

AD Line5.6M

CMF (20d)0.086

Volume Metrics

Avg Vol (20d)0.2K

Vol Ratio0.5x(Low)

VWMA (20d)$0.31

Pivot Points

R3$0.32

R2$0.32

R1$0.32

Pivot Point$0.32

S1$0.32

S2$0.32

S3$0.32

Advanced Oscillators

TSI-6.27

Ultimate Osc41.6

KST-50.38

Financial Data

Quarter	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Cost of Revenue	$0	N/A	N/A	$0	$0	$0	N/A	$0	$0	$0	N/A	$0
Gross Profit	$0	N/A	N/A	$0	$0	$0	N/A	$0	$0	$0	N/A	$0

Operating Expenses	$2.62M	$2.26M	$2.33M	$1.89M	$2.59M	$2.41M	$1.34M	$1.66M	$2.76M	$2.54M	$2.49M	$2.86M
R&D	$1.16M	$809,991	$1.13M	$638,324	$1.22M	$1.31M	$467,706	$748,339	$1.06M	$1.27M	$1.42M	$1.09M
SG&A	$1.46M	$1.45M	$1.20M	$1.25M	$1.37M	$1.10M	$872,661	$915,912	$1.70M	$1.27M	$1.08M	$1.77M
Operating Income	$-2,619,910	$-2,260,260	$-2,330,884	$-1,892,322	$-2,588,151	$-2,412,124	$-1,340,367	$-1,664,251	$-2,760,459	$-2,543,678	$-2,494,389	$-2,864,041

Interest Income	$85,410	$109,616	$122,583	$102,257	$7,067	$26,006	$50,218	$68,084	$75,522	$55,198	$4,439	$79,152
Interest Expense	$17,439	$17,439	$17,439	$245,182	$59,696	$59,697	$59,696	$59,696	$31,838	$0	$767	$0
Income Before Tax	$-1,999,397	$-2,158,354	$-2,144,828	$-1,676,169	$-2,463,030	$-2,200,736	$-1,349,969	$-1,653,542	$-2,717,369	$-2,480,823	$-2,495,156	$-2,797,971
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-1,999,397	$-2,158,354	$-2,144,828	$-1,676,169	$-2,463,030	$-2,200,736	$-1,349,969	$-1,653,542	$-2,717,369	$-2,480,823	$-2,495,580	$-2,797,971

EBITDA	$-2,067,368	$-2,140,915	$-2,232,533	$-1,288,062	$-2,350,705	$-2,107,348	$-1,280,795	$-1,602,234	$-2,729,215	$-2,536,021	$-2,499,595	$-2,877,123
EBIT	$-2,067,368	$-2,140,915	$-2,249,972	$-1,533,244	$-2,410,401	$-2,167,045	$-1,340,491	$-1,661,930	$-2,761,053	$-2,536,021	$-2,499,595	$-2,877,123

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about ANEB

News

Anebulo Pharmaceuticals, Inc. Revenue Breakdown – LS:A3CM1D

This article provides a financial overview of Anebulo Pharmaceuticals, Inc. (A3CM1D) on TradingView, focusing on its revenue breakdown. It lists various financial data sections available, such as statements, statistics...

TradingView•Jul 26, 2026 2:10 PM ET7/26/26•Neutral

ANEB Valuation and Fair Value

P/FCF: -2.2x
P/B: 1.6x

See GNG's fair value

ANEB Profitability: Margins, ROIC and FCF

FCF yield: -45.9%

ANEB Competitors

Company	Ticker
GT Biopharma Inc	GTBP
Synlogic Inc	SYBX
Femasys Inc	FEMY
Tharimmune Inc.	THAR
Biofrontera Inc	BFRI
Pluri Inc.	PLUR
Tvardi Therapeutics, Inc.	TVRD
In8bio Inc	INAB

Sector: Healthcare

ANEB Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: 21.2%
EPS estimate (fiscal period ending Jun 30, 2026): $-0.09

Frequently Asked Questions About ANEB

Does ANEB pay dividends?

Anebulo Pharmaceuticals Inc (ANEB) does not currently pay a regular dividend.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In